Retreatment with Recombinant Interferon- in Patients with Chronic Hepatitis C
Authors
Discussion
Loading...
Member takes
Implication
Clinical evaluation assesses retreatment with recombinant interferon-alpha in chronic hepatitis C, indicating therapeutic potential for nonresponders or relapsers.
Key Points
- To assess the efficacy and clinical outcomes of retreatment with recombinant interferon-alpha in patients with chronic hepatitis C who previously failed or relapsed after therapy.
- Interventional retreatment study evaluating recombinant interferon-alpha administration in patients diagnosed with chronic hepatitis C.
- Monitoring of biochemical markers such as serum alanine aminotransferase and viral response parameters during and after the retreatment period.
- Therapeutic retreatment with interferon-alpha induces secondary biochemical normalization and viral clearance in a subset of chronic hepatitis C patients.
- Sustained response rates depend heavily on prior treatment response history and patient compliance during the extended retreatment regimen.
Cite This Study
Marcellin et al. (1993) studied this question.